Dionysis Papadatos-Pastos: First line treatment for EGFR driven NSCLC in the context of MARIPOSA and FLAURA2

Dionysis Papadatos-Pastos shared a post on X:

”My recent presentation in vumedi…discussing 1L treatment for EGFR driven NSCLC in the context of MARIPOSA and FLAURA2.”

Read further.
Source: Dionysis Papadatos-Pastos/X

Dionysis Papadatos-Pastos is a Consultant Medical Oncologist specializing in the treatment of lung cancer, mesothelioma, and thymoma. He practices at The London Clinic, Leaders in Oncology Care, Cromwell Hospital, University College London Hospitals NHS Foundation Trust, and Princess Alexandra Hospital NHS Trust.